Biocon says first set of biosimilars to hit European market by early 2018
Two of the biosimilars—trastuzumab and pegfilgrastim—are under review by drug regulator European Medicines Agency. Photo: Hemant Mishra/Mint Hyderabad: Bio-pharmaceutical company ...